نتائج البحث 781-790 من 4936 لعملية البحث عن Blood factor II
... blood pressure, despite use of two anti-hypertensive medications and lifestyle changes. The novelty of the RPDTM system relates to its placement via natural ...
... factors that may determine disease progression and treatment response. ... [1, 2] The solid tumor ... blood samples for future DNA/RNA sequencing , and ...
To develop a repository of blood, urine and ... This study will also help us to learn whether certain genes (inherited factors ... توجّه للصفحة 22 · توجّه للصفحة 33 ...
... factors known to ... These include but are not limited to improvements in: (i) receiver coils; (ii) ... We further examine whether blood biomarkers can ...
The purpose of this study is to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive ...
Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and docetaxel ...
Rochester, Minn. This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or ...
The purpose of this study is to confirm detection of the H3K27M mutation in patient biofluids (CSF, blood ... 2 or 3 meningioma as measured by 6-month PFS rate.
The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.